Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 12 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 9096602

    Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  2. US 9096584

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  3. US 9090619

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  4. US 9090614

    Processes and intermediates for producing azaindoles

    Vertex Pharmaceuticals Incorporated · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  5. US 9079916

    Heteroaryl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  6. US 9073875

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  7. US 9067932

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  8. US 9062008

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  9. US 9051319

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  10. US 9051270

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  11. US 9051303

    Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-YL)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan-2-YL)-1H-indol-5-YL)-cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  12. US 9051324

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  13. US 9045425

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  14. US 9040542

    Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea

    Vertex Pharmaceuticals Incorporated · Granted May 26, 2015 · Expires May 21, 2035

    granted

  15. US 9035072

    Process of producing cycloalkylcarboxamido-indole compounds

    Vertex Pharmaceuticals Incorporated · Granted May 19, 2015 · Expires May 14, 2035

    granted

  16. US 9029546

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2015 · Expires May 7, 2035

    granted

  17. US 9018216

    Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  18. US 9012473

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  19. US 9012496

    Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  20. US 8999976

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  21. US 8993600

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  22. US 8987454

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  23. US 8969386

    Modulators of CFTR

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  24. US 8969382

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.